Expands epinephrine administration mechanisms permitted in schools, institutions of higher education, and youth camps.*

S 4545 expands New Jersey schools, colleges, and youth camps' ability to administer epinephrine during anaphylaxis emergencies by allowing any FDA-approved device - not just pre-filled auto-injectors. It directly affects students with severe allergies, their parents/guardians (who must provide written authorization and physician orders), and school staff (including nurses and trained designees). Key provisions require schools to maintain accessible, secure epinephrine supplies, ensure staff are trained per Department of Education protocols, and retain existing liability protections for schools. The bill does not change parental authorization requirements but modernizes device options to include all FDA-approved mechanisms.